Author:
Mohammadi Zakyieh,Jalili Masomah,Gholami Tayebe,Nalbandian Mohamadali,Jouzi Mina
Reference35 articles.
1. [1] Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785-802. [DOI:10. 1038/s41569-021-00559-8] [PMID] [PMCID]
2. [2] Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, Gregg EW, Bennett JE, Solomon B, Singleton RK, Sophiea MK. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957-80. [DOI:10.1016/S0140-6736 (21)01330-1] [PMID] [PMCID]
3. [3] Dokunmu TM, Yakubu OF, Adebayo AH, Olasehinde GI, Chinedu SN. Cardiovascular risk factors in a suburban community in Nigeria. Int J Hypertens. 2018:6898527. [DOI:10.1155/2018/6898527] [PMID] [PMCID]
4. [4] Khezeli M. Study on the prevalence of hypertension and its associated factors in the elderly population. La Revue du praticien. 2012;62(9):1225-8.
5. [5] Baghi V, Baghban Karimi E, Jafari H, Ghanei Gheshlagh R. [Predicting the Quality of Life of Patients With Hypertension Based on Resilience and Social Support (persian)]. IJPN. 2018;5(6):24-30. [Link]